Juvenescence Ltd - 16 Feb 2023 Form 4 Insider Report for AgeX Therapeutics, Inc. (SER)

Role
Director, 10%+ Owner
Signature
/s/ Gregory Bailey, Executive Chairman of Juvenescence Ltd.
Issuer symbol
SER
Transactions as of
16 Feb 2023
Net transactions value
$0
Form type
4
Filing time
17 Feb 2023, 06:01:51 UTC
Previous filing
08 Feb 2023
Next filing
22 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGE Warrant to Purchase Common Stock Award $0 +801,924 $0.000000 801,924 16 Feb 2023 Common Stock 801,924 $0.6235 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Warrants issued in connection with the draw of loan funds under an Amended and Restated Secured Convertible Promissory Note between the issuer and the reporting person.
F2 The warrants are exercisable for shares of the issuer's common stock upon issuance.

Remarks:

Director by deputization